Sale of Securities

BridgeBio Pharma, Inc. Filed 2025-02-25 Acc 0001950047-25-001237

Documents 1

2025-03-05 144 Sale of Securities
2025-02-28 8-K Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
2025-02-27 3 Initial Statement of Ownership
2025-02-27 4 CFO and Treasurer sold 8,500 shares at an average $33.19 ($282,115)
2025-02-27 4 Chief Executive Officer sold 75,000 shares at an average $33.57 ($2,517,971)
2025-02-25 144 Sale of Securities
2025-02-25 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…